- Home
- DYAI vs AMSS Comparison
DYAI vs AMSS Comparison
Compare DYAI & AMSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | AMSS |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 30.6M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYAI | AMSS |
|---|---|---|
| Price | $1.00 | $1.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 220.4K | ★ 412.4K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,090,345.00 | N/A |
| Revenue This Year | $122.79 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.83 |
| 52 Week High | $1.60 | $2.44 |
Technical Indicators
Market Signals| Indicator | DYAI | AMSS |
|---|---|---|
| Relative Strength Index (RSI) | 47.49 | 41.01 |
| Support Level | $0.76 | $0.83 |
| Resistance Level | $1.21 | $1.30 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 10.77 | 57.69 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About AMSS AMASS Brands Inc. Common Stock
Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.